#medical-research

#medical-research

Euston's 1960s office tower is being revamped to create a more modern, mixed-use space, combining office and medical research facilities.

David Landon pioneered high-resolution electron microscopy for neuromuscular disease diagnosis, significantly aiding research and understanding of conditions like multiple sclerosis.

PRGN-2012 shows promise as a gene therapy for recurrent respiratory papillomatosis, potentially reducing the need for multiple surgeries.

Combination treatment of danicopan with C5 inhibitors shows promise in improving anemia in PNH patients resistant to previous therapies.

Cure3 is a charity art exhibition aimed at benefiting Parkinson's medical research.

The cancellation of NIH panels threatens funding for crucial medical research and health initiatives.

The cannabis industry is experiencing rapid growth and gaining recognition for its medical and wellness benefits, thanks to pioneering figures like Dr. Mechoulam and Nancy Whiteman.

BMI is an imperfect tool indicating obesity and should be replaced or supplemented with better metrics.

Obesity can be categorized into clinical and preclinical to improve diagnosis and treatment.

A new framework for obesity diagnosis offers a more objective and globally applicable method.

The reclassification of cannabis to Schedule III marks a significant move towards federal legalization and enhanced opportunities for research and financial services.

The DEA continues to deny cannabis' medicinal benefits despite extensive scientific evidence, reflecting outdated drug policy biases.

IdentifyHer's Peri wearable targets perimenopause symptoms, providing valuable insights and data for users.

Focus on creating actionable insights rather than just tracking traditional health metrics.